Archives of Clinical Infectious Diseases
Infectious Diseases and Tropical Medicine Research Center, SBUMS
Authors
Intravenous drug use (IDU) is a frequent route of infection transmission, especially during the recent decades. Numerous studies have addressed the increasing frequency of IDU-associated infections such as hepatitis and AIDS. The present study was achieved to determine the prevalence of IDU-associated infections in 3 teaching hospitals in Iran.
For this descriptive study, 3 teaching hospitals affiliated to Shaheed Beheshti University of Medical Sciences were considered and patients who had been admitted in infectious ward were included. Totally, 126 IDU patients were evaluated for duration of drug abuse, type of drug, site and frequency of injections, and clinical manifestations.
The study population included 123 males and 3 females with a mean age of 37 years. They have averagely abused IV drugs for 5.8 years 3.3 times a day. Groin (44%) and upper extremity (forearm, arm or hand) (36%) were the most common sites of injection. Soft tissue and skin infection, respiratory infections and pulmonary TB, and viral hepatitis were the most common IDU-associated infections.
Skin and soft tissues were the most common site of involvement among IDU patients. High frequency of pulmonary tuberculosis in IDU necessitates clinicians attention; however, the association between TB and HIV was remarkable.
© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Alavi SM. Relative frequency of infections among hospitalized injecting drug user-HIV positive patients in Razi hospital, Ahvaz, SW Iran (2001-2003). Jundishapur J Microbiol. 2008;1(1):. doi:
Alavi S, Behdad F. Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006). Hepat Mon. 2010;10(2):. doi:
Amin-Esmaeili M, Amin-Esmaeili M, Rahimi-Movaghar A, Rahimi-Movaghar A, Razaghi E, et al. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2011;12(1):. doi: https://doi.org/10.5812/kowsar.1735143X.806
Khorvash F, Fasihi Dastjerdi M, Emami Naeini A. Paraclinical disorders and prevalence of viral infections in injection drug users. J Inflamm Dis. 2024;13(2):e155465. doi:
Tavakkoli H, Mir-Nasseri M, Poustchi H, Afshar P, Motalebi M, et al. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002). Hepat Mon. 2008;8(1):. doi:
Last Update: 1 month ago
Last Update: 1 month ago
Last Update: 1 month ago
Last Update: 5 days ago
Last Update: 2 hours ago
Last Update: 2 days ago
